You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
本港新增614宗新冠肺炎確診 初步陽性逾600宗 今波疫情58%患者已接種兩劑疫苗
阿思達克 02-07 17:29
衛生署衛生防護中心傳染病處主任張竹君在記者會上表示,本港新增614宗新型冠狀病毒確診個案,7宗爲輸入個案,607宗爲本地感染,當中約150宗與早前個案相關,其餘患者感染源頭仍在調查中。至於初步陽性個案亦超過600宗。另外,昨日(6日)公佈的342宗個案,有219宗未知源頭。 衛生署衛生防護中心總監徐樂堅表示,近日本地感染個案持續上升,部分確診個案與節日聚集有關,相信明日(8日)個案會進一步上升,呼籲市民減少聚集及外出,但認爲現時仍然有能力控制疫情,不過需要較多時間。 他提到,當局明日會啓用竹篙灣社區隔離設施,安排較低風險的確診者到該處接受隔離,而明日亦會開始居安抗疫計劃,確診者的密切接觸者及次密切接觸者,需進行14日或4日家居檢疫。 張竹君又稱,未有源頭個案涉及較多需面對人羣的職業,例如售貨員、清潔員、保安及地盤工人等,或與此等行業頻密檢測有關。 此外,她稱當局不會再公佈確診個案的詳情,認爲已沒有甚麼意義。而去年12月31日至今的確診者,有58%已接種兩劑疫苗,以12歲以上確診者計則爲66%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account